About Pharmaforce Medex Private Limited
Data last updated:
Pharmaforce Medex Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2019PTC461316. Its GSTIN is 02AAKCP8846L1ZW (Himachal Pradesh).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9 Cr. It is led by directors including Nikunj Tyagi (Whole-Time Director) and Satish Kumar Sharma.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.7 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹9.22 Lakh (net margin 1.2%) and EBITDA of ₹78.08 Lakh (EBITDA margin 10.1%). Revenue has grown at a compounded annual rate (CAGR) of 482% over three years.
As per MCA filings, the company has open charges of ₹41.32 Lakh on record. The company has 2 deals on record (2 rights issues); the latest was in December 2021. Its 10 peer companies in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Sasvat Omnicare Private Limited with revenue of ₹7.71 Cr.
For more details, the company can be reached via its website mankindpharma.com.
Company details
CIN history
Pharmaforce Medex has one previous CIN (Corporate Identification Number): U24230HP2019PTC007703. The current CIN is U24230DL2019PTC461316, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230DL2019PTC461316 | Current |
| U24230HP2019PTC007703 | Previous |
Contact details
Pharmaforce Medex Private Limited's registered office is in New Delhi, Delhi.
- Social Media
- Registered Address208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pharmaforce Medex is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pharmaforce Medex Private Limited, buy the company report.
Financials of Pharmaforce Medex Private Limited
FY 2025 filings availablePharmaforce Medex Private Limited reported revenue of ₹7.7 Cr (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 482% over three years, including 31% growth in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹78.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharmaforce Medex Private Limited, buy the company report.
Board of directors of Pharmaforce Medex Private Limited
Pharmaforce Medex has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satish Kumar Sharma | Director | 16 May 2024 | 2 Years 5 Months | Current |
| Nikunj Tyagi Also directs: Yvns Momkidsfashion LLP, Sirmour Remedies Private Limited, Shriom Organics Private Limited and 4 more | Whole-Time Director | 28 Jul 2020 | 6 Years 2 Months | Current |
| Arjun Singh Also directs: Sirmour Remedies Private Limited, Mediforce Research Private Limited, Medipack Innovations Private Limited and 1 more | Director | 24 Jul 2024 | 2 Years 3 Months | Current |
Peer comparison
Pharmaforce Medex Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sasvat Omnicare Private Limited | ₹7.71 Cr (FY 2024) | -73.0% | Bangalore, Karnataka, India | |||
| Agrix Seeds Private Limited | ₹7.71 Cr (FY 2025) | 41083.0% | Gandhinagar, Gujarat, India | |||
| Anar Mcat Advanced Electronic Chemicals Private Limited | ₹7.71 Cr (FY 2025) | 74.0% | Ahmedabad, Gujarat, India | |||
| Kemix Chemicals and Coating Private Limited | ₹7.71 Cr (FY 2025) | 37.0% | Mumbai, Maharashtra, India | |||
| SNJ Lifecare Private Limited | ₹7.7 Cr (FY 2025) | -6.0% | Rajkot, Gujarat, India | |||
| Pharmaforce Medex Private Limitedthis company | ₹7.7 Cr (FY 2025) | ₹9.22 Lakh | 1.2% | 31.0% | New Delhi, Delhi, India | |
| Pynat Corporation India Private Limited | ₹7.7 Cr (FY 2017) | 46.0% | Bangalore, Karnataka, India | |||
| Ayurpark Health Care Limited | ₹7.69 Cr (FY 2021) | 24.0% | Bangalore, Karnataka, India | |||
| Earthchem Laboratories Private Limited | ₹7.68 Cr (FY 2023) | -44.0% | Pune, Maharashtra, India | |||
| Mr Big Fire Works Private Limited | ₹7.68 Cr (FY 2024) | 13.0% | Virudhunagar, Tamil Nadu, India | |||
| Sunny Industries Pvt Ltd | ₹7.68 Cr (FY 2025) | -3.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Pharmaforce Medex Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2024 | 100893044 | Others | ₹41.32 Lakh | Open |
Total charge records: 1 View all charges
Deals & funding
Pharmaforce Medex Private Limited has 2 deals on record (2 rights issues); the latest was in December 2021.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2021 | Rights issue | ₹6 Cr | Investors: Appian Properties Private Limited , 2 individuals |
| Nov 2019 | Rights issue | ₹2.99 Cr | Investors: Appian Properties Private Limited , 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Pharmaforce Medex Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmaforce Medex Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pharmaforce Medex has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAKCP8846L1ZW | Himachal Pradesh | Active | 15 Jan 2020 |
To see the full GST registrations and return filing status of Pharmaforce Medex Private Limited, buy the company report.
Recent activity
Pharmaforce Medex Private Limited has 8 board changes on record since 2020: 3 appointments and 5 cessations. The latest: Arjun Singh ceased to be Additional Director on 24 Sep 2024.
Frequently asked questions
Pharmaforce Medex is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 November 2019 (7+ years old) and is registered under CIN U24230DL2019PTC461316.
Pharmaforce Medex has 3 current directors:
- Nikunj Tyagi - Whole-Time Director
- Satish Kumar Sharma - Director
- Arjun Singh - Director
The latest financial statements of Pharmaforce Medex on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Pharmaforce Medex is 02AAKCP8846L1ZW, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Pharmaforce Medex is U24230DL2019PTC461316. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmaforce Medex was incorporated on 20 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Pharmaforce Medex has 2 deals on record (2 rights issues); the latest was in December 2021.
The peers of Pharmaforce Medex by revenue are Sasvat Omnicare Private Limited, Agrix Seeds Private Limited, Anar Mcat Advanced Electronic Chemicals Private Limited, Kemix Chemicals and Coating Private Limited, SNJ Lifecare Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Arjun Singh ceased to be Additional Director on 24 Sep 2024. Satish Kumar Sharma ceased to be Additional Director on 24 Sep 2024. Arjun Singh was appointed as Director on 24 Jul 2024. Pharmaforce Medex has 8 board changes on record in total.
Pharmaforce Medex can be reached through the website mankindpharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Pharmaforce Medex is at 208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020.